A study to establish the technical and economic feasibility of a mobile DNA and RNA testing tool, for use in general clinics and homecare.

Informazioni relative al progetto

BiomemeDx

ID dell’accordo di sovvenzione: 729930

DOI

10.3030/729930

Progetto chiuso

Data della firma CE 24 Settembre 2016

Data di avvio 1 Giugno 2016

Data di completamento 30 Settembre 2016

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

BIOMEME UK LTD
United Kingdom

Periodic Reporting for period 1 - BiomemeDx (A study to establish the technical and economic feasibility of a mobile DNA and RNA testing tool, for use in general clinics and homecare.)

Periodo di rendicontazione: 2016-06-01 al 2016-09-30

Sintesi del contesto e degli obiettivi generali del progetto

The Biomeme-Fluorogenics partnership are working together to commercialise a handheld DNA testing machine called Three9, and a modular, compact manufacturing line to produce specialised kits for it called PodLab. Together we have worked on the specification for our two systems and investigated their commercial viability. In all, we expect Three9 to eventually democratise molecular diagnostics, and allow such tests to be carried out in point of care scenarios, humanitarian crises, and for other functions in the near future. These alternate functions include testing food, cosmetics, and pharmaceuticals for contamination and allergens, and bioterrorism defences. The current focus is on the testing for and tracking of infectious diseases. PodLabs is a miniaturised version of large production lines used to mass-produce commonly-used DNA test kits. As infectious diseases emerge and evolve so quickly, and because Three9 also targets underserviced illnesses, self-contained short-run production is seen as an ideal solution to its needs. Together the systems can also support development of new tests for diseases in research institutions - Three9 will provide the tester, and PodLabs will provide the production capacity at low cost.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

We investigated the state of the market as a whole, our customer segments, our technical and economic competitors, and developed a comprehensive business plan based on these factors, and an assessment of our technologies. The technological assessment includes a vision of the products at full-scale rollout, and the product development plan needed to reach this stage. In addition we developed commercialisation and communication plans, and an IP strategy to be implemented during the product development plan.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

Three9 is capable of testing for more conditions at one time than competitors, and integrates cloud storage and analysis for the raw data generated during the polymerase chain reaction DNA test on which the technology is based. This allows for exact identification of diseases like malaria and Dengue fever, both of which display identical symptoms but require radically different treatments. The human-machine interface for the device is an app which provides a simple readout for the user that both patients and doctors can interpret clearly. PodLabs is, thus far, unique in its intentions and applications. Laboratory automation providers typically focus on the supply of individual machines, while PodLabs provides for a miniaturised short-run production facility, built around familiar equipment.

Biomeme Device